Live Attenuated S. Typhimurium Vaccine with Improved Safety in Immuno-Compromised Mice

• Balamurugan Periaswamy,

  Affiliation Institute of Microbiology, D-BIOL, ETH Zürich, Zürich, Switzerland

  ⨯
• Lisa Maier,

  Affiliation Institute of Microbiology, D-BIOL, ETH Zürich, Zürich, Switzerland

  ⨯
• Vikalp Vishwakarma,

  Affiliation School of Biotechnology, KIIT University, Bhubaneswar, Odisha, India

  ⨯
• Emma Slack,

  Affiliation Institute of Microbiology, D-BIOL, ETH Zürich, Zürich, Switzerland

  ⨯
• Marcus Kremer,

  Affiliation Städtisches Klinikum München, München, Germany

  ⨯
• Helene L. Andrews-Polymenis,

  Affiliation The Vaccine Research Institute of San Diego, San Diego, California, United States of America

  ⨯
• Michael McClelland,

  Affiliation The Vaccine Research Institute of San Diego, San Diego, California, United States of America

  ⨯
• Andrew J. Grant,

  Affiliation Department of Veterinary Medicine and Cambridge Infectious Diseases Consortium, University of Cambridge, Cambridge, United Kingdom

  ⨯
• Mrutyunjay Suar,

  Affiliation School of Biotechnology, KIIT University, Bhubaneswar, Odisha, India

  ⨯
• Wolf-Dietrich Hardt

  * E-mail: hardt@micro.biol.ethz.ch

  Affiliation Institute of Microbiology, D-BIOL, ETH Zürich, Zürich, Switzerland

  ⨯